Characteristics of Peripheral Blood Eosinophils in Patients with Nocturnal Asthma
- 1 March 1992
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 145 (3) , 577-581
- https://doi.org/10.1164/ajrccm/145.3.577
Abstract
A number of mechanisms have been proposed to explain nocturnal exacerbations of asthma including circadian patterns in circulating cortisol and catecholamines. These factors may influence airway smooth muscle tone and circulating eosinophil characteristics and function. Because recent evidence has indicated that eosinophils contribute to airway inflammation and the severity of asthma, we evaluated the relationship among peripheral blood eosinophils, their density distribution, and the appearance of nocturnal asthma. Fifteen patients with asthma were evaluated. Spirometry (FEV1 and FVC) was determined at 0400 and 1600, and the number and density distribution of peripheral blood eosinophils were determined. Five patients had nocturnal asthma, defined as a 15% or greater fall in FEV1 at 0400 versus 1600. The patients with nocturnal asthma had greater numbers of eosinophils (cells x 10(6)/ml) at 0400 (0.845 +/- 0.13 versus 0.351 +/- 0.03) and 1600 (0.651 +/- 0.18 versus 0.319 +/- 0.07) and a greater circadian variation with peak eosinophilia at 0400. Furthermore, we found a significant circadian increase in low-density eosinophils (as determined by Percoll density gradient centrifugation) at 0400, but only in patients with nocturnal asthma. These observations suggest that a circadian variation in low density eosinophils may contribute to nocturnal exacerbations of asthma.Keywords
This publication has 8 references indexed in Scilit:
- Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.Journal of Clinical Investigation, 1988
- Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.The Journal of Experimental Medicine, 1988
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988
- Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.The Journal of Experimental Medicine, 1987
- Release of Leukotriene C4 from Human Eosinophils and its Relation to the Cell DensityInternational Archives of Allergy and Immunology, 1985
- Airway Cooling and Nocturnal AsthmaChest, 1982
- Standardization of bronchial inhalation challenge proceduresJournal of Allergy and Clinical Immunology, 1975
- Nocturnal and morning asthma. Relationship to plasma corticosteroids and response to cortisol infusion.Thorax, 1975